Puma Biotechnology, Inc.
38 clinical trials · Sponsor
◉ Watch Puma Biotechnology, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC) (NCT07465757) | Puma Biotechnology, Inc. | 2026-09-30 |
| A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (NCT06369285) | Puma Biotechnology, Inc. | 2024-11-19 |
| A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer (NCT06095505) | Puma Biotechnology, Inc. | 2024-02-08 |
| A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib (NCT04366713) | Puma Biotechnology, Inc. | 2020-06-30 |
| HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib (NCT03786107) | Puma Biotechnology, Inc. | 2019-03-14 |
Track Puma Biotechnology, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.